Table 1. Spectral analysis (HF, LF and normalized HF), RMSSD and fetal stress index values before and after direct intravenous administration of 2.5 mg atropine.
The results are presented as median values (1st–3rd quartiles). A Wilcoxon test was used for analysis. Statistical significance was set as p <0.05.
Before | %CV before | After | %CV after | p | Effect size | |
---|---|---|---|---|---|---|
HF | 52.9(37.2–75) | 33.4 | 25.4(21.1–39.1) | 30.2 | 0.043 | 1.13 |
LF | 22.3(16–31.1) | 35.2 | 18.1(14–41.8) | 51.1 | 0.398 | 0.35 |
HF/(HF+LF) | 0.68(0.61–0.78) | 11.6 | 0.53(0.47–0.65) | 18.3 | 0.018 | 0.92 |
RMSSD | 8.7(6.3–9.2) | 49.3 | 4(3–6.5) | 37.6 | 0.018 | 1.13 |
FSI | 57.3(52.4–61.2) | 9.9 | 40.4(36–46.2) | 17.3 | 0.018 | 1.49 |
HF = high frequency; LF = low frequency,
RMSSD = root mean square of the successive differences;